TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 09 2024
0mins
Source: Benzinga
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ADUS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ADUS
Wall Street analysts forecast ADUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADUS is 133.00 USD with a low forecast of 117.00 USD and a high forecast of 147.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 102.480
Low
117.00
Averages
133.00
High
147.00
Current: 102.480
Low
117.00
Averages
133.00
High
147.00
About ADUS
Addus HomeCare Corporation is engaged in providing home care services. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
10 Small-Cap Stocks Set to Surge in 2026
- Small-Cap Stocks Performance: Small-cap stocks have started 2026 with strong momentum, indicating a positive trend in the market.
- Market Potential: Many of these companies are positioned to outperform the market, suggesting that the rally could continue.
Continue Reading
ADDUS HOMECARE Corporation Rating Upgraded to 100% Indicating Strong Growth Potential
- Rating Upgrade: ADDUS HOMECARE's rating has been upgraded from 50% to 100% based on James P. O'Shaughnessy's strategy, reflecting significant improvements in the company's fundamentals and stock valuation, indicating strong market confidence in its future growth.
- Industry Positioning: As a mid-cap growth stock in the Healthcare Facilities sector, ADDUS HOMECARE provides personal care, hospice, and home health services, addressing the daily living needs of the elderly and chronically ill, highlighting its importance in the rapidly growing home care market.
- Investment Appeal: According to O'Shaughnessy's strategy, a score above 80% typically indicates interest in the stock, while scores above 90% suggest strong interest; ADDUS's new rating may attract more institutional investors, potentially driving up the stock price.
- Market Outlook: With an aging population and increasing demand for home care services, ADDUS HOMECARE is poised to capture greater market opportunities, and the company's growth potential and profitability are expected to significantly enhance in the coming years.
Continue Reading